Works matching AU PARK, CHEOL-YOUNG


Results: 92
    1
    2
    3
    4
    5

    Front Cover.

    Published in:
    Diabetes, Obesity & Metabolism, 2023, v. 25, n. 1, p. C1, doi. 10.1111/dom.14939
    By:
    • Moon, Sun Joon;
    • Kim, Kyung‐Soo;
    • Lee, Woo Je;
    • Lee, Mi Yeon;
    • Vigersky, Robert;
    • Park, Cheol‐Young
    Publication type:
    Article
    6
    7

    Efficacy and safety of evogliptin treatment in patients with type 2 diabetes: A multicentre, active‐controlled, randomized, double‐blind study with open‐label extension (the EVERGREEN study).

    Published in:
    Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1527, doi. 10.1111/dom.14061
    By:
    • Kim, Gyuri;
    • Lim, Soo;
    • Kwon, Hyuk‐Sang;
    • Park, Ie B.;
    • Ahn, Kyu J.;
    • Park, Cheol‐Young;
    • Kwon, Su K.;
    • Kim, Hye S.;
    • Park, Seok W.;
    • Kim, Sin G.;
    • Moon, Min K.;
    • Kim, Eun S.;
    • Chung, Choon H.;
    • Park, Kang S.;
    • Kim, Mikyung;
    • Chung, Dong J.;
    • Lee, Chang B.;
    • Kim, Tae H.;
    • Lee, Moon‐Kyu
    Publication type:
    Article
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40

    An Internet-based health gateway device for interactive communication and automatic data uploading: Clinical efficacy for type 2 diabetes in a multi-centre trial.

    Published in:
    2017
    By:
    • Jae Hyoung Cho;
    • Hun-Sung Kim;
    • Seung Hyun Yoo;
    • Chang Hee Jung;
    • Woo Je Lee;
    • Cheol Young Park;
    • Hae Kyung Yang;
    • Joong Yeol Park;
    • Sung Woo Park;
    • Kun Ho Yoon;
    • Cho, Jae Hyoung;
    • Kim, Hun-Sung;
    • Yoo, Seung Hyun;
    • Jung, Chang Hee;
    • Lee, Woo Je;
    • Park, Cheol Young;
    • Yang, Hae Kyung;
    • Park, Joong Yeol;
    • Park, Sung Woo;
    • Yoon, Kun Ho
    Publication type:
    journal article
    41
    42
    43
    44
    45

    A randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise.

    Published in:
    Diabetes/Metabolism Research & Reviews, 2015, v. 31, n. 3, p. 295, doi. 10.1002/dmrr.2613
    By:
    • Jung, Chang Hee;
    • Park, Cheol‐Young;
    • Ahn, Kyu‐Joeng;
    • Kim, Nan‐Hee;
    • Jang, Hak‐Chul;
    • Lee, Moon‐Kyu;
    • Park, Joong‐Yeol;
    • Chung, Choon‐Hee;
    • Min, Kyung‐Wan;
    • Sung, Yeon‐Ah;
    • Park, Jeong‐Hyun;
    • Kim, Sung Jin;
    • Lee, Hyo Jung;
    • Park, Sung‐Woo
    Publication type:
    Article
    46
    47
    48
    49
    50